Sign Out
Click on icon to see table/diagram/imageAdverse reactions reported with the use of eye drops containing phosphate buffers: Cases of corneal calcification have been reported very rarely in association with the use of phosphate-containing eye drops in some patients with significantly damaged corneas.
Paediatric population: In two short-term clinical trials (≤12 weeks), involving 93 (25 and 68) paediatric patients the safety profile was similar to that in adults and no new adverse events were identified. The short-term safety profiles in the different paediatric subsets were also similar (see Pharmacology: Pharmacodynamics under Actions). Adverse events seen more frequently in the paediatric population as compared to adults are: nasopharyngitis and pyrexia.
View ADR Reporting Link
Continue with Google